Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Reducing Total Cardiovascular Risk in an Urban Community (COACH)
This study is ongoing, but not recruiting participants.
Study NCT00241904 Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: October 17, 2005 Last Updated: July 10, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Diseases
Heart Diseases
Coronary Disease
Diabetes Mellitus
Atherosclerosis
Cerebral Arteriosclerosis
Hypertension
Additional conditions recognized in this trial
Arteriosclerosis
Coronary Artery Disease
Intracranial Arteriosclerosis
More general conditions related to this trial
Arterial Occlusive Diseases
Brain Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Endocrine System Diseases
Glucose Metabolism Disorders
Intracranial Arterial Diseases
Metabolic Diseases
Myocardial Ischemia
Nervous System Diseases
Vascular Diseases
Interventions listed in this trial
Lifestyle Changes
Antiplatelet Agents
Beta Blocker
ACE Inhibitors
Additional drug interventions recognized in this trial
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Platelet Aggregation Inhibitors
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Back to top of Main Content
